Jubilant Pharmova posts Q1 net profit of Rs 160 crore
The company had posted a net profit of Rs 35.39 crore for the year-ago period, Jubilant Pharmova said in a regulatory filing With a gradual recovery in nuclear medicine procedures, the turnaround plan of radio pharmacy business is on track (Source: PTI) PTI
Updated Jul 24, 2021, 9:13 AM IST
Drug firm Jubilant Pharmova on Friday reported a consolidated net profit of Rs 160.49 crore from continuing operations for the quarter ended June 30, 2021. The company had posted a net profit of Rs 35.39 crore for the year-ago period, Jubilant Pharmova said in a regulatory filing.
Revenue from continuing operations stood at Rs 1,634.65 crore in the quarter under review. It was Rs 1,156.07 crore in the same period a year ago, it added.
Jubilant Pharmova posts Q1 consolidated net profit of Rs 160 crore business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.